Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy
about
Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled TrialsNext Steps Toward Eradication of Hepatitis C in the Era of Direct Acting AntiviralsConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy.On the occasion of the world hepatitis day: world hepatitis day and our achievements and responsibilities in iran.The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C.The Efficacy and Safety of Sofosbuvir-Containing Regimen in the Treatment of HCV Infection in Patients with HaemoglobinopathyThe treatment of HCV in patients with haemoglobinopathy in Kurdistan Region, Iraq: a single centre experience.Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran.HBV and HCV coinfection associated with warm-type autoimmune hemolytic anemia: a case report.
P2860
Q26745895-BE3EB213-B1BE-4864-AA16-FC66D8C4D0FFQ26747561-091C9507-1BB2-442D-BCA9-82FA302E83C2Q30417045-413D2A18-3F3A-4F42-992F-5EAFBF80D5C2Q34042394-A1807EC0-C0FB-437A-9BBC-7EEC0675307BQ35131583-E0E4C5DB-4591-48BD-9EF3-1C54513C962BQ36151827-E53BD6DC-1647-4EDB-9317-BFB45FEE6074Q36805359-7606E3F8-36DE-40AD-9A24-0BC06D7A1984Q40364801-3807FAC6-3836-4341-BFB8-D706C2FB2FD4Q40694971-609A2A4E-283F-4824-A45C-1234F03AAC7BQ42252742-27C01B6F-817A-41D3-9B72-C221FD5ED0C5Q43095876-61C4A0A4-2C48-43F6-93CF-02A0FAD1B1A1
P2860
Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Low dose ribavirin for treatme ...... ations for combination therapy
@ast
Low dose ribavirin for treatme ...... ations for combination therapy
@en
type
label
Low dose ribavirin for treatme ...... ations for combination therapy
@ast
Low dose ribavirin for treatme ...... ations for combination therapy
@en
prefLabel
Low dose ribavirin for treatme ...... ations for combination therapy
@ast
Low dose ribavirin for treatme ...... ations for combination therapy
@en
P2093
P2860
P50
P356
P1433
P1476
Low dose ribavirin for treatme ...... ations for combination therapy
@en
P2093
Ahmad Gharehbaghian
Bashir Hajibeigy
Bita Behnava
Kamran Bagheri Lankarani
Pegah Karimi Elizee
Sedigheh Amini Kafiabad
Seyed Vahid Tabatabaei
P2860
P304
P356
10.5812/HEPATMON.6592
P407
P577
2012-06-30T00:00:00Z